Any current/future new fundraising through debt or equity?

Current repayment of Rs. 125 crores in debt is being serviced entirely from internal cash generation; no new borrowing for this repayment (Page 14). Short-term borrowing is around Rs. 25-26 crores, and there is a rotational short-term funded borrowing of Rs. 330-340 crores included in creditors (Page 14). Long-term debt has reduced by Rs. 100 crores to Rs. 409 crores; cash on books is Rs. 170 crores, resulting in net debt of about Rs. 280 crores (Page 13 & 5). Routine maintenance CAPEX of Rs. 35-40 crores will be funded from internal accruals; however, growth CAPEX will be funded through bank

Any current/future capex/capital investment/strategic investment?

Routine CAPEX: Rs. 35 to Rs. 40 crores per annum funded from internal accruals. Efficiency CAPEX: Rs. 15 to Rs. 20 crores for operational improvements. Growth CAPEX: To be funded through bank borrowings; final plans to be announced soon. Focus on making South facility chlorine neutral with additional CAPEX over next 1 to 1.5 years; aims to balance chlorine usage and add value-added products. Potential future diversification into new chemistries is under discussion but premature to share details. Completed major payment of Rs. 125 crores for growth projects in CPVC and SIOP. Invested Rs. 20 cro

Future growth expectations in sales/revenue/volumes?

CPVC capacity expanded to 20,000 tons per annum with plans to operate at full capacity and increase sales. SIOP production capacity to be increased from 18,000 tons to around 27,000-28,000 tons after debottlenecking; targeting sales of 25,000-26,000 tons in FY25. Specialty Chemical segment expected to drive growth with higher volume focus despite volatile pricing; goal to increase specialty EBITDA contribution beyond 50%. For FY25, the company aims to leverage capacity additions in CPVC and SIOP to grow volumes substantially, compensating for price pressures. Plans to improve margins a

Future growth expectations in earnings/operating earnings/profits/EPS?

DCW aims to increase Specialty Chemicals EBITDA to over 50% of total EBITDA, providing bottom-line stability. Growth capex is planned to expand capacity in CPVC (from 12,000 to 20,000 tons per annum) and SIOP (from 18,000 to ~27,000-28,000 tons), expecting to fill increased capacity by FY25. Specialty segments (SIOP, CPVC, Synthetic Rutile) are targeted as key profit contributors with elevated margins compared to commodities. Commodity segments like Caustic Soda continue under pressure with limited profitability; focus remains on value-added products. Management foresees revenue growth driven

Current/ Expected Orderbook/ Pending Orders?

The transcript does not explicitly mention the current or expected order book or specific pending orders for DCW Limited. However, management highlights strong demand in Specialty Chemicals, particularly in CPVC and SIOP, with plans to increase capacity and sales volumes. SIOP sales target for FY25 is around 25,000 to 26,000 tons, up from approximately 20,000 tons sold in FY24. CPVC production capacity has been expanded to 20,000 tons per annum with full utilization expected. Synthetic Rutile is operating at around 90% capacity with good export demand. The company is optimistic about filling i

DCWQ4 FY24Chemicals & Petrochemicals

DCW Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹44.6P/E: 20.2Market Cap: ₹1.4K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

CPVC capacity expanded to 20,000 tons per annum with plans to operate at full capacity and increase sales.
SIOP production capacity to be increased from 18,000 tons to around 27,000-28,000 tons after debottlenecking; targeting sales of 25,000-26,000 tons in FY25.
Specialty Chemical segment expected to drive growth with higher volume focus despite volatile pricing; goal to increase specialty EBITDA contribution beyond 50%.
For FY25, the company aims to leverage capacity additions in CPVC and SIOP to grow volumes substantially, compensating for price pressures.
Plans to improve margins and sales stability through value-added products and operational efficiencies.
Demand across products except Caustic Soda is considered reasonably strong with opportunities in both domestic and international markets.

Margin guidance

Category 3

DCW aims to increase Specialty Chemicals EBITDA to over 50% of total EBITDA, providing bottom-line stability.
Growth capex is planned to expand capacity in CPVC (from 12,000 to 20,000 tons per annum) and SIOP (from 18,000 to ~27,000-28,000 tons), expecting to fill increased capacity by FY25.
Specialty segments (SIOP, CPVC, Synthetic Rutile) are targeted as key profit contributors with elevated margins compared to commodities.
Commodity segments like Caustic Soda continue under pressure with limited profitability; focus remains on value-added products.
Management foresees revenue growth driven by volume increases in Specialty chemicals rather than price hikes due to volatile market prices.
CAPEX for growth will be partly funded by bank borrowings; routine maintenance CAPEX funded from internal accruals.
Earnings growth expected to improve in H2 FY25 as recent capacity additions stabilize and market demand picks up.

See what DCW management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

Current repayment of Rs. 125 crores in debt is being serviced entirely from internal cash generation; no new borrowing for this repayment (Page 14).
Short-term borrowing is around Rs. 25-26 crores, and there is a rotational short-term funded borrowing of Rs. 330-340 crores included in creditors (Page 14).
Long-term debt has reduced by Rs. 100 crores to Rs. 409 crores; cash on books is Rs. 170 crores, resulting in net debt of about Rs. 280 crores (Page 13 & 5).
Routine maintenance CAPEX of Rs. 35-40 crores will be funded from internal accruals; however, growth CAPEX will be funded through bank borrowings (Page 12).
No indication of raising equity or fresh fundraising through equity at present (throughout transcript).
Discussions are ongoing for growth CAPEX, and an announcement is expected soon, which may involve further bank borrowings but not explicit equity raising (Page 12).

Order book

The transcript does not explicitly mention the current or expected order book or specific pending orders for DCW Limited.
However, management highlights strong demand in Specialty Chemicals, particularly in CPVC and SIOP, with plans to increase capacity and sales volumes.
SIOP sales target for FY25 is around 25,000 to 26,000 tons, up from approximately 20,000 tons sold in FY24.
CPVC production capacity has been expanded to 20,000 tons per annum with full utilization expected.
Synthetic Rutile is operating at around 90% capacity with good export demand.
The company is optimistic about filling increased capacity in SIOP within a year to year and a half, indicating a healthy order inflow.
Focus is on volume growth and expanding domestic and international markets, though no explicit order backlog numbers are provided.

See what DCW management said on order book — free account, 30 seconds.

Capex plans

Yes

Routine CAPEX: Rs. 35 to Rs. 40 crores per annum funded from internal accruals.
Efficiency CAPEX: Rs. 15 to Rs. 20 crores for operational improvements.
Growth CAPEX: To be funded through bank borrowings; final plans to be announced soon.
Focus on making South facility chlorine neutral with additional CAPEX over next 1 to 1.5 years; aims to balance chlorine usage and add value-added products.
Potential future diversification into new chemistries is under discussion but premature to share details.
Completed major payment of Rs. 125 crores for growth projects in CPVC and SIOP.
Invested Rs. 20 crores in group Captive Solar project; financial benefits expected from H2 FY25.
Capacity expansions underway: CPVC capacity increased to 20,000 tons per annum; SIOP capacity to increase from 18,000 to 27,000-28,000 tons post debottlenecking.

Track DCW — get its next earnings analysis in your feed

How does DCW rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisDCW

Rev 3Mar 3

See where DCW sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does DCW rank in Chemicals & Petrochemicals?

Compare DCW against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What DCW's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

Prasol Chemicals Ltd (Q1 FY27)
Q1 FY27 Revenue from Operations: ₹433.6 crores . Key investor presentation takeaways from Prasol Chemicals Ltd's Q1 FY27 investor presentation — and how it rank
Vipul Organics Ltd (Q4 FY26)
Q4 FY26 (Mar 2026) total revenue: ₹5,262.37 lakhs (Consolidated) . Key concall takeaways from Vipul Organics's Q4 FY26 earnings call — and how it ranks against…
Vipul Organics Ltd (Q1 FY27)
Q1 FY27 net revenue: ₹51.78 crore, up +37.7% YoY (Page 13) . Key concall takeaways from Vipul Organics's Q1 FY27 earnings call — and how it ranks against…
Fine Organic Industries Ltd (Q1 FY27)
Revenue from Operations (Consolidated) for Q1FY27: Rs 694.2 Cr, up 18.0% YoY from Rs 588.4 Cr in Q1FY26 (Page 34). Key concall takeaways from Fine Organic…

Compare:vs Solar Industries India Ltd vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

DCW Q4 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does DCW rank in Chemicals & Petrochemicals?

Continue your research

What DCW's management said in earlier quarters

Others in Chemicals & Petrochemicals this season